BRNS vs GRMN · $38.2M cap vs P/E 28, rev $7.25B
Barinthus Biotherapeutics plc (BRNS) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
BRNS currently screens at market cap $38.2M. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the BRNS and GRMN stock pages for the full models.
Not investment advice.